The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Metabolomics Biomarker Market Research Report 2024
Synopsis
The global Metabolomics Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Metabolomics Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Metabolomics Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Metabolomics Biomarker in Toxicological studies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Metabolomics Biomarker include Biocrates Life Sciences, Biomark Diagnostics, Chenomx, Creative Proteomics, Evotec, Human Metabolome Technologies, Merck, Metabolomic Diagnostics and Metabolon, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Metabolomics Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolomics Biomarker.
Report Scope
The Metabolomics Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metabolomics Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metabolomics Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocrates Life Sciences
Biomark Diagnostics
Chenomx
Creative Proteomics
Evotec
Human Metabolome Technologies
Merck
Metabolomic Diagnostics
Metabolon
Ovid Therapeutics
Segment by Type
Protein Marker
Nucleic Acid Marker
Segment by Application
Toxicological studies
Drug testing
Cancer
Cardiovascular disorders
Neurological disorders
Inborn errors of metabolism
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metabolomics Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Metabolomics Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Metabolomics Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Metabolomics Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Metabolomics Biomarker in Toxicological studies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Metabolomics Biomarker include Biocrates Life Sciences, Biomark Diagnostics, Chenomx, Creative Proteomics, Evotec, Human Metabolome Technologies, Merck, Metabolomic Diagnostics and Metabolon, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Metabolomics Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolomics Biomarker.
Report Scope
The Metabolomics Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metabolomics Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metabolomics Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocrates Life Sciences
Biomark Diagnostics
Chenomx
Creative Proteomics
Evotec
Human Metabolome Technologies
Merck
Metabolomic Diagnostics
Metabolon
Ovid Therapeutics
Segment by Type
Protein Marker
Nucleic Acid Marker
Segment by Application
Toxicological studies
Drug testing
Cancer
Cardiovascular disorders
Neurological disorders
Inborn errors of metabolism
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metabolomics Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metabolomics Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Protein Marker
1.2.3 Nucleic Acid Marker
1.3 Market by Application
1.3.1 Global Metabolomics Biomarker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Toxicological studies
1.3.3 Drug testing
1.3.4 Cancer
1.3.5 Cardiovascular disorders
1.3.6 Neurological disorders
1.3.7 Inborn errors of metabolism
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metabolomics Biomarker Market Perspective (2019-2030)
2.2 Metabolomics Biomarker Growth Trends by Region
2.2.1 Global Metabolomics Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Metabolomics Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Metabolomics Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Metabolomics Biomarker Market Dynamics
2.3.1 Metabolomics Biomarker Industry Trends
2.3.2 Metabolomics Biomarker Market Drivers
2.3.3 Metabolomics Biomarker Market Challenges
2.3.4 Metabolomics Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metabolomics Biomarker Players by Revenue
3.1.1 Global Top Metabolomics Biomarker Players by Revenue (2019-2024)
3.1.2 Global Metabolomics Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Metabolomics Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metabolomics Biomarker Revenue
3.4 Global Metabolomics Biomarker Market Concentration Ratio
3.4.1 Global Metabolomics Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolomics Biomarker Revenue in 2023
3.5 Metabolomics Biomarker Key Players Head office and Area Served
3.6 Key Players Metabolomics Biomarker Product Solution and Service
3.7 Date of Enter into Metabolomics Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metabolomics Biomarker Breakdown Data by Type
4.1 Global Metabolomics Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Metabolomics Biomarker Forecasted Market Size by Type (2025-2030)
5 Metabolomics Biomarker Breakdown Data by Application
5.1 Global Metabolomics Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Metabolomics Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Metabolomics Biomarker Market Size (2019-2030)
6.2 North America Metabolomics Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Metabolomics Biomarker Market Size by Country (2019-2024)
6.4 North America Metabolomics Biomarker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metabolomics Biomarker Market Size (2019-2030)
7.2 Europe Metabolomics Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Metabolomics Biomarker Market Size by Country (2019-2024)
7.4 Europe Metabolomics Biomarker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metabolomics Biomarker Market Size (2019-2030)
8.2 Asia-Pacific Metabolomics Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Metabolomics Biomarker Market Size by Region (2019-2024)
8.4 Asia-Pacific Metabolomics Biomarker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metabolomics Biomarker Market Size (2019-2030)
9.2 Latin America Metabolomics Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Metabolomics Biomarker Market Size by Country (2019-2024)
9.4 Latin America Metabolomics Biomarker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metabolomics Biomarker Market Size (2019-2030)
10.2 Middle East & Africa Metabolomics Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Metabolomics Biomarker Market Size by Country (2019-2024)
10.4 Middle East & Africa Metabolomics Biomarker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocrates Life Sciences
11.1.1 Biocrates Life Sciences Company Detail
11.1.2 Biocrates Life Sciences Business Overview
11.1.3 Biocrates Life Sciences Metabolomics Biomarker Introduction
11.1.4 Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2019-2024)
11.1.5 Biocrates Life Sciences Recent Development
11.2 Biomark Diagnostics
11.2.1 Biomark Diagnostics Company Detail
11.2.2 Biomark Diagnostics Business Overview
11.2.3 Biomark Diagnostics Metabolomics Biomarker Introduction
11.2.4 Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2019-2024)
11.2.5 Biomark Diagnostics Recent Development
11.3 Chenomx
11.3.1 Chenomx Company Detail
11.3.2 Chenomx Business Overview
11.3.3 Chenomx Metabolomics Biomarker Introduction
11.3.4 Chenomx Revenue in Metabolomics Biomarker Business (2019-2024)
11.3.5 Chenomx Recent Development
11.4 Creative Proteomics
11.4.1 Creative Proteomics Company Detail
11.4.2 Creative Proteomics Business Overview
11.4.3 Creative Proteomics Metabolomics Biomarker Introduction
11.4.4 Creative Proteomics Revenue in Metabolomics Biomarker Business (2019-2024)
11.4.5 Creative Proteomics Recent Development
11.5 Evotec
11.5.1 Evotec Company Detail
11.5.2 Evotec Business Overview
11.5.3 Evotec Metabolomics Biomarker Introduction
11.5.4 Evotec Revenue in Metabolomics Biomarker Business (2019-2024)
11.5.5 Evotec Recent Development
11.6 Human Metabolome Technologies
11.6.1 Human Metabolome Technologies Company Detail
11.6.2 Human Metabolome Technologies Business Overview
11.6.3 Human Metabolome Technologies Metabolomics Biomarker Introduction
11.6.4 Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2019-2024)
11.6.5 Human Metabolome Technologies Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Metabolomics Biomarker Introduction
11.7.4 Merck Revenue in Metabolomics Biomarker Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Metabolomic Diagnostics
11.8.1 Metabolomic Diagnostics Company Detail
11.8.2 Metabolomic Diagnostics Business Overview
11.8.3 Metabolomic Diagnostics Metabolomics Biomarker Introduction
11.8.4 Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2019-2024)
11.8.5 Metabolomic Diagnostics Recent Development
11.9 Metabolon
11.9.1 Metabolon Company Detail
11.9.2 Metabolon Business Overview
11.9.3 Metabolon Metabolomics Biomarker Introduction
11.9.4 Metabolon Revenue in Metabolomics Biomarker Business (2019-2024)
11.9.5 Metabolon Recent Development
11.10 Ovid Therapeutics
11.10.1 Ovid Therapeutics Company Detail
11.10.2 Ovid Therapeutics Business Overview
11.10.3 Ovid Therapeutics Metabolomics Biomarker Introduction
11.10.4 Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2019-2024)
11.10.5 Ovid Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
